Pharm-Rx Bacitracin Zinc
- CAS Number
- 1405-89-6
- Chemical Name
- Bacitracin Zinc
Pharm-Rx Bacitracin Zinc contains the active ingredient bacitracin zinc and serves in over-the-counter (OTC) functions within pharmaceuticals and nutraceuticals. Classified as an active pharmaceutical Ingredient (API) under pharmaceutical actives and precursors within pharmaceuticals and nutraceuticals technologies, it's commonly utilized in various pharmaceutical formulations for its therapeutic properties.
Properties
- Physical Form
- Powder
- Pharma and Nutraceuticals Functions
- OTC
Product families
Applications
- Other Drug & Care Solutions
Product Families
- Active Pharmaceutical Ingredients (APIs)
Other characteristics
- Chemical Inventories
AICS (Australia), ECL (Korea), EINECS (EU), ENCS (Japan), NDSL (Canada), NZIoC (New Zealand), PICCS (Phillipines), TCSI (Taiwan), TSCA (USA); AICS (Australia); ECL (Korea); EINECS (EU); ENCS (Japan); NDSL (Canada); NZIoC (New Zealand); PICCS (Phillipines); TCSI (Taiwan); TSCA (USA)
- Certifications & Compliance
- California Proposition 65, FDA 29 CFR 1910.1200
- Markets
- Healthcare & Pharma
- Definition
Bacitracin Zinc is the zinc complex of bacitracin, which consists of a mixture of antimicrobial polypeptides, the main components being bacitracins A, B1, B2, and B3. It has a potency of not less than 65 Bacitracin Units/mg, calculated on the dried basis. It contains not less than 4.0% and not more than 6.0% of zinc (Zn), calculated on the dried basis.
- Technology
- Pharmaceuticals & Nutraceuticals
- FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- Labelling Information
Label it to indicate that it is to be used in the manufacture of nonparenteral drugs only. Where it is packaged for prescription compounding, label it to indicate that it is not sterile and that the potency cannot be assured for longer than 60 days after opening, and to state the number of Bacitracin Units/mg. Where it is intended for use in preparing sterile dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of sterile dosage forms.
- USP Reference Standards
- USP Bacitracin Zinc RS
- Certifications and Compliance
- California Proposition 65
- FDA 29 CFR 1910.1200
